ArticleInternational journal of biological sciences2026
Anlotinib enhances the sensitivity to docetaxel in lung cancer through inhibiting DDR1-mediated glycolytic pathway.
Xueqin Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.